Philippe Lopes-Fernandes, EVP & Chief Business Officer, shares how Ipsen’s tenacious approach to dealmaking is transforming breakthrough science into global
Philippe Lopes-Fernandes, EVP & Chief Business Officer, shares how Ipsen’s tenacious approach to dealmaking is transforming breakthrough science into global
“We all know someone affected by cancer, so for me, there’s an urgency, especially when I think about the patient.”
Ivan Diaz-Padilla, Senior Vice President and Global Head, Oncology Therapeutic Area Unit, R&D at Ipsen, shares his vision for building
Christelle Huguet, Executive Vice President, Head of R&D at Ipsen, challenges the outdated belief that bigger means better in biopharma,
“My role is to ensure that every product we develop meets the highest standards of quality, safety, efficacy, and compliance.”
Targeting what cannot be seen: Lindsey Rodrigues on the complexity of epigenetics or mutated in a particular cancer. We have
“We collaborate with our medical and chemical colleagues doing drug discovery, taking a look at the current process, and thinking
In the latest installment of our ‘A Life in Science’ series, we’re excited to introduce Crystel Ogier, our Clinical Biomarker
. Next in our ‘A Life in Science’ series, Dorinne Desposito, Predictive Toxicology Project Manager, shares her insights on driving
New in our ‘A Life in Science’ series, we hear from Christelle Huguet, Executive Vice President and Head of Research